180 related articles for article (PubMed ID: 34951345)
21. Regulations of Exosomal-Transmitted
Zhou F; Xu X; Wei W; Chen X; Sun L
Discov Med; 2023 Oct; 35(178):877-886. PubMed ID: 37811626
[TBL] [Abstract][Full Text] [Related]
22. A1BG-AS1 promotes adriamycin resistance of breast cancer by recruiting IGF2BP2 to upregulate ABCB1 in an m6A-dependent manner.
Wang J; Xu J; Zheng J
Sci Rep; 2023 Nov; 13(1):20730. PubMed ID: 38007504
[TBL] [Abstract][Full Text] [Related]
23. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis.
Liu B; Yan L; Chi Y; Sun Y; Yang X
J Ovarian Res; 2021 Apr; 14(1):60. PubMed ID: 33926489
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA SDCBP2-AS1 delays the progression of ovarian cancer via microRNA-100-5p-targeted EPDR1.
Liu X; Liu C; Zhang A; Wang Q; Ge J; Li Q; Xiao J
World J Surg Oncol; 2021 Jul; 19(1):199. PubMed ID: 34218800
[TBL] [Abstract][Full Text] [Related]
26. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
[TBL] [Abstract][Full Text] [Related]
27. Long non-coding RNA OIP5-AS1 suppresses microRNA-92a to augment proliferation and metastasis of ovarian cancer cells through upregulating ITGA6.
Wang Y; Li L; Zhang X; Zhao X
J Ovarian Res; 2022 Feb; 15(1):25. PubMed ID: 35168644
[TBL] [Abstract][Full Text] [Related]
28. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
Xu C; Zhai J; Fu Y
Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
Qin Z; Zheng X; Fang Y
Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
[TBL] [Abstract][Full Text] [Related]
31. H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis.
Ma Y; Zheng W
J Ovarian Res; 2021 Jun; 14(1):76. PubMed ID: 34108034
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA SGO1-AS1 inactivates TGFβ signaling by facilitating TGFB1/2 mRNA decay and inhibits gastric carcinoma metastasis.
Huang D; Zhang K; Zheng W; Zhang R; Chen J; Du N; Xia Y; Long Y; Gu Y; Xu J; Deng M
J Exp Clin Cancer Res; 2021 Oct; 40(1):342. PubMed ID: 34706749
[TBL] [Abstract][Full Text] [Related]
33. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
Luo N; Zhang K; Li X; Hu Y
J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
[TBL] [Abstract][Full Text] [Related]
34. Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/β-catenin pathway and associates with favorable prognosis of ovarian cancer.
Fu Y; Katsaros D; Biglia N; Wang Z; Pagano I; Tius M; Tiirikainen M; Rosser C; Yang H; Yu H
Sci Rep; 2021 Apr; 11(1):7484. PubMed ID: 33820921
[TBL] [Abstract][Full Text] [Related]
35. LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1.
Bai Y; Ren C; Wang B; Xue J; Li F; Liu J; Yang L
Cancer Gene Ther; 2022 Mar; 29(3-4):277-291. PubMed ID: 34035482
[TBL] [Abstract][Full Text] [Related]
36. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
Li H; Zhou Y; Cheng H; Tian J; Yang S
Exp Mol Pathol; 2020 Aug; 115():104481. PubMed ID: 32497621
[TBL] [Abstract][Full Text] [Related]
37. Long Non-Coding RNA HAND2-AS1 Acts as a Tumor Suppressor in High-Grade Serous Ovarian Carcinoma.
Gokulnath P; de Cristofaro T; Manipur I; Di Palma T; Soriano AA; Guarracino MR; Zannini M
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517089
[TBL] [Abstract][Full Text] [Related]
38. LncRNA TLR8-AS1 promotes metastasis and chemoresistance of ovarian cancer through enhancing TLR8 mRNA stability.
Xu Q; Lin YB; Li L; Liu J
Biochem Biophys Res Commun; 2020 Jun; 526(4):857-864. PubMed ID: 32278547
[TBL] [Abstract][Full Text] [Related]
39. m
Bian Y; Wang Y; Xu S; Gao Z; Li C; Fan Z; Ding J; Wang K
Cells; 2022 Sep; 11(19):. PubMed ID: 36230970
[TBL] [Abstract][Full Text] [Related]
40. LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca
Pan K; Xie Y
Cell Death Dis; 2020 Jun; 11(6):434. PubMed ID: 32513911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
